Based on a series of observational analyses (2, 5, 6) , the extent of viability has been used to predict a greater LV functional benefit and improved survival from coronary artery bypass graft (CABG) versus medical therapy. This practice is not supported by results of a prior analysis of data from the randomized, controlled STICH (Surgical Treatment for Systolic Heart Failure) trial (7) . However, additional studies have suggested that LV functional improvement following CABG is diminished in patients with greater LV volumes (8, 9) . These findings suggest that CABG may confer survival benefit only among patients with substantial viability, in the absence of severe that he has no relationships relevant to the contents of this paper to disclose. 
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